Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis
Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis have?
Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis has 11 citations in the OpenAlex counts ScholarIQ stores.
When was Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis published?
Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis has 2022 year in the ScholarIQ index.
What is the open-access status of Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis?
Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis has closed oa status in the ScholarIQ index.
What is the DOI of Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis?
The DOI for Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis is on the source record.
What is the PMID of Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis?
The PMID for Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis is on the source record.
What is the OpenAlex record for Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis?
The OpenAlex for Angiotensin‐converting enzyme inhibitors prior to scleroderma renal crisis in systemic sclerosis: A systematic review and meta‐analysis is on the source record.